CMS: Stay tuned for final rule on hospital price transparency

hospital
As the Trump administration released final rules around physician reimbursement and site-neutral payments as part of the Outpatient Prospective Payment System, a proposal that would require hospitals to post "shoppable prices" remains on hold—at least for now. (Getty/peterspiro)

As the Trump administration released final rules Friday around physician reimbursement and site-neutral payments as part of the Outpatient Prospective Payment System (OPPS), a proposal that would require hospitals to post "shoppable prices" remains on hold—at least for now.

In July, the Centers for Medicare & Medicaid Services (CMS) released the proposal that every U.S. hospital participating in Medicare must publish the prices they negotiate with payers for standard services and items in a bid to boost transparency. The rule is supposed to go into effect Jan. 1, 2020, as part of its outpatient payment rule.

While portions of the OPPS were released Friday, officials said the proposed requirements for hospitals to make public a list of their standard charges garnered more than 1,400 comments. "We intend to summarize and respond to public comments on the proposed policies in a forthcoming final rule," officials said in a statement.

Featured Webinar

Reducing barriers to patient care: A cross-industry collaboration

Optum will bring together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address migraines, a hard-to-diagnose condition. Learn how this team started with a model to risk stratify, predict undiagnosed, misdiagnosed and mismanaged members and how those analytics were used to enrich engagement for treatment and diagnosis optimization.

RELATED: CMS finalizes physician fee schedule rule with cuts to physical therapists, psychologists

Suggested Articles

A New Jersey medical office has filed suit against Cigna, alleging that the insurer failed to pay for diagnostic testing and treatment for COVID-19.

CMS issued new guidance Friday to help states implement the new interoperability policies in Medicaid and CHIP programs.

GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare conditions topping the ranking.